COMMENTARY Potential Role of the Quality Assurance Review Center Platform in Global Radiation Oncology Wilfred Ngwa, PhD,* Emmanuel Ikhile, MBBS, y Atara Ntekim, MBBCh, MRes, FMCR, z Nwamaka Lasebikan, MBBS, FMCR, x Adewumi Alabi, MBBS, FWACS, k Uchechukwu N. Shagaya, MBBS, { Fatiregun Omolara, MBBS, FWACS, # Musa Ali-Gombe, MBBS,** Adamu Danladi Bojude, MBBS, FMCR, FWACS, MSc,** Mamsau Ngoma, MD, yy Twalib Ngoma, MD, zz Madar Bhagwat, PhD, xx Omoruyi Credit Irabor, MBBS, MPH, jjjj Jonathan Schoenfeld, MD, jjjj Paul Nguyen, MD, kk Erno Sajo, PhD, {{ Fran Laurie, BS, ## Janaki Moni, MD,*** and Thomas J. Fitzgerald, MD yyy *Brigham and Women’s Hospital, Dana Faber Cancer Institute, Harvard Medical School, Boston; University of Massachusetts Medical School, Lowell, Massachusetts; y Department of Radiation Oncology; University of Benin Teaching Hospital, Nigeria; z Department of Radiation Oncology, University of Ibadan, Nigeria; x Department of Radiation Oncology, University of Nigeria Hospital, Nigeria; k Tygerberg Academic Hospital, Capetown, South Africa; { National Hospital, Abuja, Nigeria; # University of Lagos Teaching Hospital, Lagos, Nigeria; **Department of Radiotherapy and Oncology, Federal Teaching Hospital, Gombe, Nigeria; yy Ocean Road Cancer Institute, Dar Es Salaam, Tanzania; zz Department of Radiology/Radiotherapy Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; xx Department of Radiation Oncology, Brigham and Women’s Hospital, Boston, Massachusetts; kk Department of Radiation Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; {{ Department of Medical Physics, University of Massachusetts, Lowell, Massachusetts; ## Imaging and Radiation Oncology Core Rhode Island, University of Massachusetts Medical School, Worcester, Massachusetts; ***University of Massachusetts Memorial Healthcare; and yyy Department of Radiation Oncology, University of Massachusetts Medical School Received Mar 6, 2017, and in revised form Jun 14, 2017. Accepted for publication Jun 22, 2017. Introduction The 2014 World Health Organization (WHO) Cancer Report describes an alarming growth in the cancer burden worldwide and underscores that, of the 14 million new cases of cancer and 8.2 million cancer-related deaths per year, 60% and 70%, respectively, occur in low-income and middle-income coun- tries (LMICs) (1). These countries are the least capable of dealing with cancer without some form of collaboration. The disparities in cancer-related deaths in part reflect poignant underlying inequalities in access to radiation oncology ser- vices; also, a majority of the population groups that experience Reprint requests to: Omoruyi Credit Irabor, MBBS, MPH, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA 02115. Tel: þ1 8572516686; E-mail: omi766@mail.harvard.edu Conflict of interest: none. Int J Radiation Oncol Biol Phys, Vol. 99, No. 4, pp. 956e962, 2017 0360-3016/$ - see front matter Ó 2017 Elsevier Inc. All rights reserved. http://dx.doi.org/10.1016/j.ijrobp.2017.06.2461 Radiation Oncology International Journal of biology physics www.redjournal.org